Insights
Professional
Practice
Industry
Region
Trending Topics
Location
Type
Sort by:
Client Alerts 1 result
Client Alert | 4 min read | 05.04.26
Decentralized Clinical Trials: Key Sponsor Considerations Under FDA and EMA Guidance
The FDA and the European Medicines Agency (EMA) (jointly with the European Commission and Heads of Medicines Agencies) each have issued or updated their respective guidance addressing decentralized clinical trials (DCT), i.e., clinical trials that include trial-related activities conducted at locations other than the traditional investigative site.
